BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12043184)

  • 21. [Lichen myxedematosus and multiple myeloma type IgG/kappa].
    Krebs A; Müller A
    Hautarzt; 1980 Dec; 31(12):649-53. PubMed ID: 6782039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of immunoglobulin heavy- and light-chain measurements compared with existing techniques as a means of typing monoclonal immunoglobulins.
    Whicher JT; Wallage M; Fifield R
    Clin Chem; 1987 Oct; 33(10):1771-3. PubMed ID: 3117430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Light chain myeloma or the pitfalls of myeloma diagnosis].
    Zufferey P; Pugin P; Regamey C
    Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance.
    Papadea C; Reimer CB; Check IJ
    Ann Clin Lab Sci; 1989; 19(1):27-37. PubMed ID: 2492788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple myeloma protein with three light chains.
    Sun T; Erichson RB; Lien YY; Wu CH
    Clin Chem; 1982 May; 28(5):1227-30. PubMed ID: 6804124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong.
    Lolin YI; Chow J; Wickham NW
    Am J Clin Pathol; 1996 Oct; 106(4):449-56. PubMed ID: 8853031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin heavy and light chain isotypes in multiple myeloma patients.
    Ansari NA; Owais M; Usha
    Asian Pac J Cancer Prev; 2007; 8(4):593-6. PubMed ID: 18260735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal gammopathy in scleredema. Observations in three cases.
    Kövary PM; Vakilzadeh F; Macher E; Zaun H; Merk H; Goerz G
    Arch Dermatol; 1981 Sep; 117(9):536-9. PubMed ID: 6794460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
    Jiwani S; Bornhost J; Alapat D
    Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy.
    Gu M; Wilton R; Stevens FJ
    Contrib Nephrol; 2007; 153():156-81. PubMed ID: 17075229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular J chains in lymphoproliferative diseases.
    Kelényi G
    Virchows Arch A Pathol Anat Histopathol; 1985; 405(3):365-78. PubMed ID: 3919501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of endocapillary proliferative glomerulonephritis with macrophages phagocytosing monoclonal immunoglobulin lambda light chain.
    Watanabe H; Osawa Y; Goto S; Habuka M; Imai N; Ito Y; Hirose T; Chou T; Ohashi R; Shimizu A; Ehara T; Shimotori T; Narita I
    Pathol Int; 2015 Jan; 65(1):38-42. PubMed ID: 25410550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
    Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
    Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgD myeloma protein with "unreactive" light chain determinants.
    Cejka J; Kithier K
    Clin Chem; 1979 Aug; 25(8):1495-8. PubMed ID: 88283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myeloma and the kidney].
    Linnanvuo-Laitinen M; Huttunen K; Timonen T
    Duodecim; 1987; 103(1):42-6. PubMed ID: 3111820
    [No Abstract]   [Full Text] [Related]  

  • 36. Application of the immunoperoxidase technic to bone marrow trephine biopsies in the classification of patients with monoclonal gammopathies.
    Peterson LC; Brown BA; Crosson JT; Mladenovic J
    Am J Clin Pathol; 1986 Jun; 85(6):688-93. PubMed ID: 3085474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of benign monoclonal gammopathy and smouldering multiple myeloma from frank myeloma.
    Shimizu K; Ohnishi K; Kunii A
    Clin Exp Immunol; 1982 Dec; 50(3):596-600. PubMed ID: 6819908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexisting kappa light chain multiple myeloma and primary hyperparathyroidism.
    Toussirot E; Bille F; Henry JF; Acquaviva PC
    Scand J Rheumatol; 1994; 23(1):49-50. PubMed ID: 8108668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple myeloma with biclonal gammopathy accompanied by prostate cancer.
    Kim NY; Gong SJ; Kim J; Youn SM; Lee JA
    Korean J Lab Med; 2011 Oct; 31(4):285-9. PubMed ID: 22016684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.